Overview
Melissa Teply is a Palliative Medicine provider practicing medicine in Omaha, Nebraska.
Her clinical expertise encompasses ALK-Positive Non-Small Cell Lung Cancer, Pediatric Low-Grade Glioma (pLGG), Smoldering Multiple Myeloma, and Relapsed Refractory Multiple Myeloma (RRMM).
She is actively involved in clinical research, co-authoring 7 peer reviewed articles. Dr. Teply is currently accepting new patients.
Specialties
Licenses
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- OTHER MEDICARE
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- EPO
- HMO
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE PDP
- EPO
- HMO
- PPO
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
- MEDICARE DISCOUNT CARD
- MEDICARE PDP
- OTHER MEDICARE
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
Locations
4400 Emile St., Omaha, NE 68105
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Fred & Pamela Buffett Cancer Center - Village Pointe Health Center
Ralph Hauke is an Oncologist and a Palliative Medicine provider practicing medicine in Omaha, Nebraska. Dr. Hauke is highly rated in 62 conditions, according to our data. His clinical expertise encompasses Renal Cell Carcinoma (RCC), Urothelial Cancer, Melanoma, Prostate Cancer, and Tissue Biopsy. Dr. Hauke is currently accepting new patients.
Unmc Physicians
Lindsay Gage is a Palliative Medicine provider practicing medicine in Omaha, Nebraska. Dr. Gage is highly rated in 1 condition, according to our data. Her clinical expertise encompasses End-Stage Renal Disease (ESRD). Dr. Gage is currently accepting new patients.
Nebraska House Call Physicians PC
Arif Sattar is a Palliative Medicine provider practicing medicine in Lincoln, Nebraska. Dr. Sattar is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Seasonal Affective Disorder (SAD), End-Stage Renal Disease (ESRD), Heart Failure with Preserved Ejection Fraction (HFpEF), and Schizoaffective Disorder. Dr. Sattar is currently accepting new patients.
Frequently Asked Questions about Dr. Melissa L. Teply
How do I make an appointment with Dr. Melissa L. Teply?
You can book an appointment with Dr. Melissa L. Teply by calling their office at 402-559-4015. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Melissa L. Teply a top-rated expert for ALK-Positive Non-Small Cell Lung Cancer?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Melissa L. Teply is classified as an Experienced expert for ALK-Positive Non-Small Cell Lung Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Melissa L. Teply specialize in?
While Dr. Melissa L. Teply is a Palliative Medicine, they have specific expertise in ALK-Positive Non-Small Cell Lung Cancer, Pediatric Low-Grade Glioma (pLGG), and Smoldering Multiple Myeloma. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Palliative Medicine.
Does Dr. Melissa L. Teply participate in research or clinical trials?
Yes. Dr. Melissa L. Teply has published 7 articles and abstracts on conditions like ALK-Positive Non-Small Cell Lung Cancer. You can view a list of Dr. Melissa L. Teply's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Melissa L. Teply accept my insurance?
Dr. Melissa L. Teply accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 402-559-4015 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- ALK-Positive Non-Small Cell Lung Cancer
- Pediatric Low-Grade Glioma (pLGG)Dr. Teply isExperienced. Learn about Pediatric Low-Grade Glioma (pLGG).
- Relapsed Refractory Multiple Myeloma (RRMM)
- Smoldering Multiple MyelomaDr. Teply isExperienced. Learn about Smoldering Multiple Myeloma.